Guangdong Taienkang Pharmaceutical Co (SZSE:301263) Net Issuance of Debt : ¥109.8 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Guangdong Taienkang Pharmaceutical Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Guangdong Taienkang Pharmaceutical Co's net issuance of debt for the three months ended in Mar. 2025 was ¥79.5 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was ¥109.8 Mil.

Guangdong Taienkang Pharmaceutical Co Net Issuance of Debt Historical Data

The historical data trend for Guangdong Taienkang Pharmaceutical Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Taienkang Pharmaceutical Co Net Issuance of Debt Chart

Guangdong Taienkang Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Debt

Get a 7-Day Free Trial

52.04

-18.79

-89.48

153.64

65.86

Guangdong Taienkang Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Issuance of Debt	Get a 7-Day Free Trial															35.50	75.86	-31.00	-14.50	79.47

Guangdong Taienkang Pharmaceutical Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥109.8 Mil.

Guangdong Taienkang Pharmaceutical Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Guangdong Taienkang Pharmaceutical Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong Taienkang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Taienkang Pharmaceutical Co Ltd (SZSE:301263) » Definitions » Net Issuance of Debt

Traded in Other Exchanges

N/A

Address

No. 8, Wanji South Second Street, Taishan North Road, Building A, Longhu District, Guangdong Province, Shantou, CHN, 515041

Website

http://www.tai-kang.com.cn

Guangdong Taienkang Pharmaceutical Co Ltd is engaged in the research and development, production, sales of pharmaceutical products, medical equipment, sanitary materials, and provision of medical-technical services and technology transfer.

Executives

Li Ting	Directors, Directors, and Executives
Zhou Gui Xi	Executives
Chen Chun	Directors, executives

Guangdong Taienkang Pharmaceutical Co Headlines

No Headlines